This tender with Assistance Publique-Hôpitaux de Marseille (AP-HM), one of France’s largest and most respected hospital systems, covers Devyser Compact, the company’s genetic testing solution for rapid and reliable aneuploidy analysis. The multi-year tender represents a significant long-term partnership, further strengthening Devyser’s presence in the French diagnostics market. 

Devyser Compact is an IVDR-certified solution that detects the most common aneuploidies using a single-tube PCR test and delivers fast and accurate results with minimal lab handling time. Its proven performance and ease of implementation enables laboratories to efficiently manage routine testing. Studies have shown that around 1 in 150 pregnancies are affected by a chromosomal abnormality, and these conditions are responsible for 50% of early pregnancy losses*, underscoring the strong clinical need for reliable diagnostic tools. 

“We are honored that Assistance Publique-Hôpitaux de Marseille, has chosen Devyser Compact for their genetic testing needs,” said Jan Wahlström, CEO, Devyser. “With this tender win we continue to strengthen our commitment to diagnostic laboratories by providing solutions that evolve with their needs.” 

“France is one of the latest markets we have converted to direct business, and with this incremental win we reaffirm that we’re on track in making France another strong growth driver for the company” said Theis Kipling, CCO Devyser.

This agreement marks an important step in Devyser’s continued expansion in France and aligns with the company’s mission to deliver innovative solutions that enhance laboratory workflows and support improved patient outcomes. 

^{*LeFevre NM, Sundermeyer RL. Fetal Aneuploidy: Screening and Diagnostic Testing. Am Fam Physician. 2020 Apr 15;101(8):481-488. PMID: 32293844.}